Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

31 Jul 2014

Abstract excerpt

The prognostic value of gene expression profiling (GEP) in multiple myeloma (MM) has been reported by several groups. 1 , 2 , 3 , 4 We have previously published a 70-gene classifier (GEP70) that identifies patients with high risk for short progression-free survival (PFS) and overall survival (OS). 1 The GEP70 model was developed from data on patients enrolled in Total Therapy 2 (TT2). 1 Its discriminatory power...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Multiple Myeloma Research and Treatments
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25079174
DOI: 10.1038/leu.2014.232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myelomaPMID 25079174Read ↗

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical useSemantic proximity Read ↗

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read ↗

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myelomaSemantic proximity Read ↗

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical RoutineSemantic proximity Read ↗

A gene signature can predict risk of MGUS progressing to multiple myelomaSemantic proximity Read ↗

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1Semantic proximity Read ↗

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsSemantic proximity Read ↗

A predicted risk score based on the expression of 16 autophagy‑related genes for multiple myeloma survivalSemantic proximity Read ↗

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3Semantic proximity Read ↗

LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapySemantic proximity Read ↗

Expression of p53 protein isoforms predicts survival in patients with multiple myelomaSemantic proximity Read ↗

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratories, and treatment historySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.